Back to News
Market Impact: 0.3
Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 Earnings Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechAnalyst Estimates
Arcutis Biotherapeutics reported quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.17 by $0.11 per share. Earnings matched the $0.06 per share reported a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
ARQT-0.45
More News
- Arcutis Biotherapeutics EVP, CMO, sells $30,047 in shares
- Arcutis Biotherapeutics evp Masaru Matsuda sells $1.37M in planned share sale
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
- Snap shares fall over 10% on third-quarter earnings miss